
|Articles|October 25, 2022
AAPS Conference Highlights 2022
Author(s)Alivia Leon
Advertisement
At the AAPS 2022 conference in Boston, BioPharm International interviewed Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Co. We spoke with Vibha Jawa about her expertise in the field of cell & gene therapies, specifically CAR-T cells. Luke Schenck discussed his knowledge on co-processed APIs. To see the highlights of our interviews with these experts, click the video below.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Next-Generation Modalities Drive New Antibody Discovery
2
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
3
European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5




